# Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection

> **NCT04419233** · — · COMPLETED · sponsor: **Biogen** · enrollment: 50 (actual)

## Conditions studied

- Muscular Atrophy, Spinal

## Interventions

- **DRUG:** Nusinersen Sodium Injection

## Key facts

- **NCT ID:** NCT04419233
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-18
- **Primary completion:** 2023-11-21
- **Final completion:** 2023-11-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04419233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04419233, "Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04419233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*